Efficacy of Baricitinib in the Treatment of Chilblains Associated With the Type I Interferonopathy Aicardi-Goutières Syndrome

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40805
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Aicardi-Goutières Syndrome

2020English

Late Diagnosis and Atypical Brain Imaging of Aicardi-Goutières Syndrome: Are We Failing to Diagnose Aicardi-Goutières Syndrome-2?

Developmental Medicine and Child Neurology
Child HealthDevelopmental NeurosciencePediatricsPerinatologyNeurology
2017English

Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi–Goutières Syndrome

Journal of Immunology
AllergyImmunology
2015English

The Efficacy of Interferon-Alpha Treatment in Human T-Lymphotropic Virus Type-I-Associated Myelopathy.

Japanese Journal of Medicine
1990English

Clinical Heterogeneity Among a Three-Generation Japanese Family With D18N TREX1 Mutation for Aicardi-Goutières Syndrome / Familial Chilblain Lupus

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

Aicardi-Goutieres Syndrome

2019English

Síndrome De Aicardi-Goutières. Resumen De Las Bases Genéticas Y Sus Mecanismos

Anales de Pediatria
Child HealthPediatricsPerinatology
2008English

Elevation of Proinflammatory Cytokines in Patients With Aicardi-Goutieres Syndrome

Neurology
Neurology
2013English

Familial Chilblain Lupus Due to a Novel Mutation in TREX1 Associated With Aicardi–Goutie’res Syndrome

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy